Saroja Pharma Industries India Ltd vs Shree Pushkar Chemicals Fertilizers Ltd Stock Comparison
Saroja Pharma Industries India Ltd vs Shree Pushkar Chemicals Fertilizers Ltd Stock Comparison
Last Updated on: Apr 01, 2026
Key Highlights
The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 29.4 as of 01 Apr 15:25
. The P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Shree Pushkar Chemicals & Fertilizers Ltd changed from 14.8 on March 2021 to 14.7 on March 2025 . This represents a CAGR of -0.14% over 5 years The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Shree Pushkar Chemicals & Fertilizers Ltd changed from ₹ 421.53 crore on March 2021 to ₹ 861.96 crore on March 2025 . This represents a CAGR of 15.38% over 5 years The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Pushkar Chemicals & Fertilizers Ltd for the Dec '25 is ₹ 253.38 crore as compare to the Sep '25 revenue of ₹ 258.37 crore. This represent the decline of -1.93% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Pushkar Chemicals & Fertilizers Ltd for the Dec '25 is ₹ 26.58 crore as compare to the Sep '25 ebitda of ₹ 29.52 crore. This represent the decline of -9.96% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The net profit of Shree Pushkar Chemicals & Fertilizers Ltd changed from ₹ 12.84 crore to ₹ 18.07 crore over 7 quarters. This represents a CAGR of 21.56%
The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Pushkar Chemicals & Fertilizers Ltd changed from 13.31 % on March 2021 to 19.12 % on March 2025 . This represents a CAGR of 7.51% over 5 years .
About Saroja Pharma Industries India Ltd
Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023.
Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business.
In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.
About Shree Pushkar Chemicals & Fertilizers Ltd
Shree Pushkar Chemicals& Fertilisers Limited was incorporated as Shree Pushkar Petro Products Limited on March 29, 1993 in Mumbai.
The name of the Company was changed to Shree Pushkar Chemicals & Fertilisers Limited on March 5, 2012.
It is promoted by first generation entrepreneurs, Mr. Punit Makharia and Mr. Gautam Makharia.
The Company is engaged in the business of manufacturing and trading of Chemicals, Dyes and Dyes Intermediate, Cattle Feeds, Fertilisers and Soil Conditioner.
The company commenced its business operations with a trading business and has emerged to become one of the few manufacturers with widest range of dye intermediates in India with zero waste.
It is also amongst India's leading manufacturers of K-Acid, a dye intermediate used to manufacture reactive dyes for dying of textiles.
FAQs for the comparison of Saroja Pharma Industries India Ltd and Shree Pushkar Chemicals & Fertilizers Ltd
Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or Shree Pushkar Chemicals & Fertilizers Ltd?
Market cap of Saroja Pharma Industries India Ltd is 11 Cr while Market cap of Shree Pushkar Chemicals & Fertilizers Ltd is 975 Cr
What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and Shree Pushkar Chemicals & Fertilizers Ltd?
The stock performance of Saroja Pharma Industries India Ltd and Shree Pushkar Chemicals & Fertilizers Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Saroja Pharma Industries India Ltd and Shree Pushkar Chemicals & Fertilizers Ltd?
As of April 1, 2026, the Saroja Pharma Industries India Ltd stock price is INR ₹28.0. On the other hand, Shree Pushkar Chemicals & Fertilizers Ltd stock price is INR ₹301.6.
How do dividend payouts of Saroja Pharma Industries India Ltd and Shree Pushkar Chemicals & Fertilizers Ltd compare?
To compare the dividend payouts of Saroja Pharma Industries India Ltd and Shree Pushkar Chemicals & Fertilizers Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.